Erythropoietin (subcutaneous or intravenous at varying dosages) vs placebo
Lack of efficacy withdrawal · anemia in patients with rheumatoid arthritis
The review found no eligible studies for this question.
1 finding from 1 review
- Erythropoiesis‐stimulating agents for anemia in rheumatoid arthritis 2013 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found